To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
Clinical trial NCT05997602 · RECRUITING
Trial details
- NCT number
- NCT05997602
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2025-05-14
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.